𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Telomerase Activity in Tumor and Remnant Liver as Predictor of Recurrence and Survival in Hepatocellular Carcinoma after Resection

✍ Scribed by Yan-Shen Shan; Yu-Hsiang Hsieh; Pin-Wen Lin

Publisher
Springer
Year
2007
Tongue
English
Weight
175 KB
Volume
31
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Quantitation of telomerase activity in h
Quantitation of telomerase activity in hepatocellular carcinoma: A possible aid for a prediction of recurrent diseases in the remnant liver
✍ Takeshi Suda; Osamu Isokawa; Yutaka Aoyagi; Minoru Nomoto; Kazuhiro Tsukada; Tak πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

Because telomerase activity is necessary for cell immortality and probably associated with tumor progression, we have evaluated a possible aid for quantitation of the activity to predict intrahepatic recurrences after surgery in patients with hepatocellular carcinoma (HCC). HCC tissues obtained by s

Preoperative tumor marker doubling time
Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma
✍ Toshiro Masuda; Toru Beppu; Kei Horino; Hiroyuki Komori; Hiromitsu Hayashi; Hiro πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 223 KB

## Abstract ## Background and Objectives It is important to identify prognostic factors in patients with hepatocellular carcinoma (HCC) before hepatectomy. No previous studies have addressed the predictive efficacy of the preoperative doubling times of alpha‐fetoprotein (AFP) and protein induced b

Prevention of hepatocellular carcinoma r
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
✍ Vincenzo Mazzaferro; Raffaele Romito; Marcello Schiavo; Luigi Mariani; Tiziana C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 563 KB

Tumor recurrence after resection of hepatocellular carcinoma (HCC) can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Interferon (IFN) has the potential for chemoprevention against hepatitis C virus (HCV)-related cirrhosis. A predetermined group of 150 HCV RNA-positive pa